Like it has been said, ONC do not cancel or back out of PanCan deal. Thst was the PanCan organization canceling ALL future " precicion promise" trials. Due to lack of/ delayed funding from Congress.
A very bad blow to ONCs progress. Not their fault @ all.
The missed presentation? Calgary had a sever westher event. Again, bad timing.
The presentation aside from possibilities, not a major blow.
Moving past thst?
IMHO, the delayed announcement of Q4 update is much more significant.
That is something 100% within Onc control.
We can speculate in any direction on that one.
There is a handful of unanswered questions. Some we may never hear an explanation for.
However Q4 by an6 measure was not good.
The PanCan deal was cancelled. Andrew G & the San Diego office cancelled.
The good news ? PanCan did agree to honour the $5 million grant towards the additional pancreatic cancer trial arm.
With AGM on the horizon, they need to greatly improve the forward looking path.
As I have said too many times. They must announce some form of funding..on a very large scale & soon.
I can nit,nore will I impose my opinions on others. Yes I will certainly offer my opinion. However would never assume others would be of same mindset.
Now, thst I have clarified/ qualified my thoughts......
Id be quite happy to see a buyout N.R. This coming Monday.
Price? $1.5 billion. Or about $18 USD/ ps.
The Canadian exchange would cover my taxes.
I appreciate the comparables the others have posted $5-$10billion sweet spots etc.
Saying that & being realistic. Onc is in a miserable negotiation position right now. Had the PanCan proceeded , they would have a lot more leaversge.
Regardless of what Onc or Onc shareholders want, the company is only worth the discounted value of forward expected income.
" discounted" ... The closer they are to getting Pela to market, the less discount applied to the future value calculations.
We know they are planning in phase 3 , pancreatic cancer trial using Roche Tecentriq. We also know the MBc phase 3 trial " collaboration" says TBD.
Meaning lots of loose ends.
Are they delaying Q4 N.R. , waiting for loose ends to be tied up? That is my guess.
No other reason makes sense.